Enhanced muscle and fat metabolism support
Proposed mechanisms include autonomic nervous system modulation and potential direct cardiac effects via GLP-1 receptors
Wegovy belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and works by mimicking the natural hormone GLP-1
Please try again
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)